Gotowe bibliografie tematyczne / Cardiovascular disease / Książki

Książki na temat „Cardiovascular disease”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Cardiovascular disease.
Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 15 czerwca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „Cardiovascular disease”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

Cardiovascular disease. Ibadan: Spectrum Books, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Gallo, Linda L., red. Cardiovascular Disease. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4684-5296-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Wang, Qing K., red. Cardiovascular Disease. Totowa, NJ: Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-159-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Lorimer, A. Ross, i W. Stewart Hillis. Cardiovascular Disease. London: Springer London, 1986. http://dx.doi.org/10.1007/978-1-4471-3120-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Akinkugbe, O. O. Cardiovascular disease. Oxford: Blackwell Scientific, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Akinkugbe, O. O. Cardiovascular disease. Ibadan: Spectrum Books, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

1943-, Hillis W. Stewart, red. Cardiovascular disease. Berlin: Springer-Verlag, 1985.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Cardiovascular disease. New York, N.Y: Facts on File, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Wood, David. Cardiovascular disease prevention. London: Mosby, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Gallo, Linda L., red. Cardiovascular Disease 2. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1959-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

Geraldine, O'Gara, i Medical Education Partnership, red. Diabetes & cardiovascular disease. London: Medical Education Partnership, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Administration, Florida Agency for Health Care. Women and cardiovascular disease: Cardiovascular hospitalizations. Tallahassee, Fla: AHCA, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Andrew, Steptoe, Rosengren Annika i SpringerLink (Online service), red. Stress and Cardiovascular Disease. London: Springer-Verlag London Limited, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Peplow, Philip, James Adams i Tim Young, red. Cardiovascular and Metabolic Disease. Cambridge: Royal Society of Chemistry, 2015. http://dx.doi.org/10.1039/9781782622390.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Johnstone, Michael T., i Aristidis Veves. Diabetes and Cardiovascular Disease. New Jersey: Humana Press, 2001. http://dx.doi.org/10.1385/1592590918.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Johnstone, Michael T., i Aristidis Veves, red. Diabetes and Cardiovascular Disease. Totowa, NJ: Humana Press, 2005. http://dx.doi.org/10.1385/1592599087.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Obesity and cardiovascular disease. Oxford: Oxford University Press, 2009.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

Cicero, Arrigo F. G., i Manfredi Rizzo, red. Nutraceuticals and Cardiovascular Disease. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-62632-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

Barbaro, Giuseppe, i Franck Boccara, red. Cardiovascular Disease in AIDS. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Paneni, Francesco, i Francesco Cosentino. Diabetes and Cardiovascular Disease. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-17762-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

Dhalla, Naranjan S., Heinz Rupp, Aubie Angel i Grant N. Pierce, red. Pathophysiology of Cardiovascular Disease. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-1-4615-0453-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

Andreadis, Emmanuel A., red. Hypertension and Cardiovascular Disease. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39599-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Yusuf, Syed Wamique, i Jose Banchs, red. Cancer and Cardiovascular Disease. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-62088-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

Nagano, Makoto, Seibu Mochizuki i Naranjan S. Dhalla, red. Cardiovascular Disease in Diabetes. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3512-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Bourassa, Martial G., i Jean-Claude Tardif, red. Antioxidants and Cardiovascular Disease. Boston, MA: Springer US, 2006. http://dx.doi.org/10.1007/0-387-29553-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

Hjemdahl, Paul, Andrew Steptoe i Annika Rosengren, red. Stress and Cardiovascular Disease. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-84882-419-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Descovich, Giancarlo, Antonio Gaddi, Gianluigi Magri i Sergio Lenzi, red. Atherosclerosis and Cardiovascular Disease. Dordrecht: Springer Netherlands, 1990. http://dx.doi.org/10.1007/978-94-009-0731-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

Tardif, Jean-Claude, i Martial G. Bourassa, red. Antioxidants and Cardiovascular Disease. Dordrecht: Springer Netherlands, 2000. http://dx.doi.org/10.1007/978-94-011-4375-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

Angel, Aubie, Naranjan Dhalla, Grant Pierce i Pawan Singal, red. Diabetes and Cardiovascular Disease. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-1321-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Nishikimi, Toshio, red. Adrenomedullin in Cardiovascular Disease. Boston, MA: Springer US, 2005. http://dx.doi.org/10.1007/b107323.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

Freeman, Lita A., red. Lipoproteins and Cardiovascular Disease. Totowa, NJ: Humana Press, 2013. http://dx.doi.org/10.1007/978-1-60327-369-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

Barbaro, Giuseppe, i Franck Boccara, red. Cardiovascular Disease in AIDS. Milano: Springer Milan, 2005. http://dx.doi.org/10.1007/b138963.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Patel, Vinood B., i Victor R. Preedy, red. Biomarkers in Cardiovascular Disease. Dordrecht: Springer Netherlands, 2015. http://dx.doi.org/10.1007/978-94-007-7741-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

Iacobellis, Gianluca. Obesity and cardiovascular disease. Oxford: Oxford University Press, 2009.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Anthony, Ware J., i Simons Michael, red. Angiogenesis and cardiovascular disease. New York: Oxford University Press, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

K, Robinson Malcolm, i Thomas Abraham 1965-, red. Obesity and cardiovascular disease. New York: Taylor & Francis, 2006.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

G, Julian Desmond, red. Thrombolysis in cardiovascular disease. New York: M. Dekker, 1989.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

Iacobellis, Gianluca. Obesity and cardiovascular disease. Oxford: Oxford University Press, 2009.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

McQuarrie, Emily P., Hallvard Holdaas, Bengt Fellström i Alan G. Jardine. Cardiovascular disease. Redaktor Jeremy R. Chapman. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0285.

Pełny tekst źródła
Streszczenie:
Premature cardiovascular disease is much more common in renal transplant recipients than the general population, although less common than in patients relying on maintenance haemodialysis. Cardiovascular disease in renal transplant recipients differs from the traditional atherosclerotic model. Although ordinary risk factors such as age, gender, diabetes, hypertension, and smoking still apply, others such as left ventricular hypertrophy and uraemic cardiomyopathy are relevant. Transplantation also adds specific risks such as immunosuppressive therapies and acute rejection. Understanding and managing the cardiovascular risk in this population is limited by a lack of large-scale randomized trials. The approach to managing the cardiovascular risk profile of these patients should be multifactorial and start even before transplantation.
Style APA, Harvard, Vancouver, ISO itp.
40

Johnston, Derek W. Cardiovascular disease. Oxford University Press, 2015. http://dx.doi.org/10.1093/med:psych/9780192627254.003.0014.

Pełny tekst źródła
Streszczenie:
Chapter 14 explores the role of behavioural medicine in the treatment of cardiovascular disease. It discusses stress management in the treatment of primary hypertension, coronary heart disease, and angina pectoris, along with rehabilitation, and future developments for research and treatment.
Style APA, Harvard, Vancouver, ISO itp.
41

Telford, Richard, i Peter Murphy. Cardiovascular disease. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198719410.003.0003.

Pełny tekst źródła
Streszczenie:
This chapter describes the anaesthetic management of the patient with cardiovascular disease. The topics include ischaemic heart disease (including perioperative myocardial infarction and percutaneous coronary intervention), valvular heart disease (including prosthetic valves), congenital heart disease, cardiomyopathy, pericardial disease, and the patient with a transplanted heart. For each topic, preoperative investigation and optimization, treatment, and anaesthetic management are described.
Style APA, Harvard, Vancouver, ISO itp.
42

Telford, Richard, i Peter Murphy. Cardiovascular disease. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198719410.003.0003_update_001.

Pełny tekst źródła
Streszczenie:
This chapter describes the anaesthetic management of the patient with cardiovascular disease. The topics include ischaemic heart disease (including perioperative myocardial infarction and percutaneous coronary intervention), valvular heart disease (including prosthetic valves), congenital heart disease, cardiomyopathy, pericardial disease, and the patient with a transplanted heart. For each topic, preoperative investigation and optimization, treatment, and anaesthetic management are described.
Style APA, Harvard, Vancouver, ISO itp.
43

Caroline, Mara, Ryan Bradley i Mimi Guarneri. Cardiovascular Disease. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190466268.003.0013.

Pełny tekst źródła
Streszczenie:
The older population is challenging to treat for numerous reasons, including comorbid conditions and increased susceptibility to adverse drug reactions, limiting medical therapy. They are at increased risk for loneliness and depression, which strongly impacts their cardiovascular outcomes, and they also have different values, usually prioritizing quality of life over mortality objectives. Finally, the elderly are underrepresented in cardiovascular clinical trials, thus limiting the applicability of guideline recommendations. This chapter emphasizes the importance of a comprehensive assessment of individual circumstances when assessing cardiovascular health in the elderly population. The chapter focuses on the role of nutrition, resiliency, and exercise for the prevention and treatment of cardiovascular disease. Nutrient deficiencies commonly seen with cardiovascular drugs are also discussed, as well as specific integrative strategies for optimizing dyslipidemia, atrial fibrillation, and heart failure in this population.
Style APA, Harvard, Vancouver, ISO itp.
44

Wohl, David A., i Jeffrey T. Kirchner. Cardiovascular Disease. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0041.

Pełny tekst źródła
Streszczenie:
There is a growing body of evidence that HIV-infected persons are at increased risk for cardiovascular disease (CVD) and associated complications, including myocardial infarction and stroke. Autopsy studies have noted premature atherosclerosis in HIV-infected adults, and epidemiological studies demonstrate higher rates of CVD among HIV-infected compared to HIV-uninfected patients. These findings are in part due to chronic inflammation and immune activation associated with HIV infection. Traditional CVD risk factors, including hypertension, hyperlipidemia, and cigarette smoking, also play keys roles. There is additional evidence from observational cohort studies that some antiretroviral drugs, including protease inhibitors and nucleoside reverse transcriptase inhibitors, may increase the risk of myocardial infarction. Treatment interventions to reduce the risk of CVD include diet, exercise, smoking cessation, lipid-lowering agents, and antihypertensive medications. For select patients, changing antiretroviral therapy to improve lipid profiles may be appropriate but should not compromise virologic or immunologic control.
Style APA, Harvard, Vancouver, ISO itp.
45

Cardiovascular Disease. Springer, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

Cardiovascular Disease. MDPI, 2021. http://dx.doi.org/10.3390/books978-3-0365-0993-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

Hatfield, Anthea. Cardiovascular disease. Oxford University Press, 2014. http://dx.doi.org/10.1093/med/9780199666041.003.0018.

Pełny tekst źródła
Streszczenie:
Cardiovascular disease is common and patients coming to recovery room with any of these common problems will need special care. The essential signs and symptoms of hypertension, cardiac failure, ischaemic heart disease, and valvular heart disease are outlined. The actions and side-effects of the drugs that these patients take to control their symptoms are described. Recognizing and treating hypotension and myocardial ischaemia are very important and relevant, and they are fully discussed in this chapter.
Style APA, Harvard, Vancouver, ISO itp.
48

Frayn, Keith, i Sara Stanner, red. Cardiovascular Disease. Wiley, 2005. http://dx.doi.org/10.1002/9780470774663.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
49

Stanner, Sara, Sarah Coe i Keith N. Frayn, red. Cardiovascular Disease. Wiley, 2018. http://dx.doi.org/10.1002/9781118829875.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
50

Lorimer, A. R., i William Stewart Williams. Cardiovascular Disease. Springer London, Limited, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany bibliografiami na temat „Cardiovascular disease” dla innych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii